
Keywords: قانون کنترل مواد سمی; Acute systemic toxicity; Alternative approaches; Non-animal methods; Regulatory requirements; LD50; LC50; In vitro; In silico; AEGL; Acute Exposure Guideline Level; CBER; FDA Center for Biologics Evaluation and Research; CDER; FDA Center for Drug Evaluati